Healthcare
Pear Healthcare invests in healthcare software companies that pioneer innovative care delivery models and enhance the healthcare tech stack across providers, payers and pharma with the goal to improve patient outcomes, enhance access to quality care, and drive positive transformation in the field of healthcare.
How we invest How we help foundersPear perspectives
Here are some of the things we’re interested in, but there are far more than what we’ve shared on this page. If you’re building something cool, we want to hear from you, regardless of whether it’s listed here or not.
Healthcare AI
The US healthcare system has reached a crucial juncture, presenting immense opportunities to leverage new data standards and the abundance of healthcare data. This, in turn, enables the development of AI solutions that enhance and automate both non-clinical and clinical workflows, optimizing efficiency and improving patient outcomes.
Tech-enabled care delivery
Envision a world where every patient, irrespective of their condition or background, can effortlessly receive timely, personalized, and specialized care from the comfort of their own home.
Healthcare tech stack
Despite advancements, many software systems in healthcare still rely on outdated methods like fax machines and hand-written forms. Providers should prioritize clinical care rather than being burdened with disjointed records, scheduling, note-taking, or compliance tasks attributed to their systems.
Healthcare fintech
Exciting new avenues to translate new modalities of fintech in healthcare. These include value-based contracting, revenue cycle management and back office automation, which aim to drive accessible care by reducing costs and inefficiencies in outdated payment systems. These modalities hold promise for a more streamlined and affordable healthcare experience, while rewarding providers for quality care.
Pharma R&D and commercial
By leveraging software, we can streamline the drug discovery, development, and distribution process, ensuring that groundbreaking medicines reach patients more efficiently. This entails facilitating pre-clinical and commercial collaboration, expediting scientific discovery and clinical trials, and ensuring regulatory compliance. With these advancements, we can accelerate the delivery of innovative treatments to those in need.
The team at PearVC was tremendously helpful when it came time to raise our series A. We couldn’t be happier with the partnership.
We received strong support on a wide range of issues from curating the right team to navigating all aspects of our Series A round.
